Hub Nexus
Updated

AuthorNo author yetClaim it

See something to improve? Propose a change.

Support

Description

Aniridia is an eye disorder that is characterized by a complete or partial absence of the colored part of the eye (the iris). Aniridia is typically present from birth (congenital) and affects both eyes. The pupils may also be abnormal or misshapen.

People with aniridia can have other eye problems that may be congenital or develop later in life. Clouding of the lenses of the eyes (cataracts) occurs in most people with aniridia. Affected individuals often have involuntary eye movements (nystagmus) or an increased sensitivity to light (photophobia). Underdevelopment of a specific region at the back of the eye (foveal hypoplasia) can reduce the sharpness of vision (visual acuity).

Additional signs and symptoms of aniridia may include problems with the cornea (aniridia-associated keratopathy). The cornea is the clear outer covering of the eye. Aniridia can also cause increased pressure in the eye (glaucoma) in late childhood through early adulthood. In some affected individuals, the structures that carry information from the eyes to the brain are underdeveloped (optic nerve hypoplasia). Many of these eye problems contribute to vision loss that worsens over time. The severity of symptoms is typically the same in both eyes.

In rare cases, individuals with aniridia have additional health problems, which can include behavioral issues, metabolic disorders, and problems detecting odors.

Aniridia can affect the eyes alone (isolated) or it can occur with other features as part of a syndrome. Aniridia is a common feature of certain genetic conditions including Gillespie syndrome and WAGR syndrome.

Injuries to the head or eyes can also cause aniridia. This type of aniridia is not genetic and can occur at any age.

Frequency

Aniridia occurs in 1 in 40,000 to 100,000 newborns worldwide.

Causes

Genetic changes that cause disease are called pathogenic variants. Pathogenic variants in the PAX6 gene can cause aniridia. The PAX6 gene provides instructions for making a protein that is involved in the early development of the eyes, brain and spinal cord (central nervous system), and the pancreas. The PAX6 protein belongs to a group of proteins called transcription factors. These proteins bind to specific regions of DNA and regulates the activity of other genes. After birth, the PAX6 protein is found in many different eye structures, where it regulates gene activity.

Pathogenic variants in the PAX6 gene cause cells to produce a nonfunctional PAX6 protein that is unable to bind to DNA and regulate the activity of other genes. Without enough functional PAX6 protein, the formation of the eyes is disrupted before birth, leading to the various signs and symptoms of aniridia.

In a small percentage of cases, aniridia can be caused by pathogenic variants in other genes. These genes produce proteins that control the expression of the PAX6 gene. Pathogenic variants in these genes lead to a reduction in PAX6 protein activity, much like variants in the PAX6 gene.

When aniridia is part of a syndrome, it is caused by gene variants associated with that syndrome.

Inheritance

Aniridia is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. In approximately two-thirds of cases, a person with aniridia inherits the pathogenic variant from one affected parent. The remaining one-third of cases result from a new (de novo) variant in the gene that occurs during the formation of reproductive cells (eggs or sperm) in an affected individual's parent or during early embryonic development. These affected individuals typically have no history of the disorder in their family.

A parent with an autosomal dominant condition passes the altered gene to two affected children. Two other children do not receive the altered gene, and are unaffected.

Autosomal dominant inheritance. Credit: U.S. National Library of Medicine.

Neither parent has the mutated gene. A spontaneous mutation occurs during the formation of an egg or sperm cell during embryonic development, leading to an affected child.

Autosomal dominant inheritance with a new (de novo) mutation. Credit: U.S. National Library of Medicine.

Other Names for This Condition

  • Absent iris
  • Congenital aniridia
  • Irideremia

Where this page came from

This page was imported from MedlinePlus Genetics, National Library of Medicine. Courtesy of MedlinePlus from the National Library of Medicine; its genetics summaries and the illustrations credited to the library are in the public domain. Pictures credited to others are not copied.

Nobody has written it yet — it is the source material at a new address, which is why search engines are asked to skip it and why no one earns from it. It is up for grabs: take it on, and it is yours to rewrite and to earn from.

LanguagesEnglish

Licence: CC0 1.0 (public domain) · Adapted from medlineplus.gov

1

0

0

0

Spinner Logo

Comments

Spinner Logo
Version: 2CC0 1.0 — public domain
The runaway star that left the Tarantula Nebula
Version: 2CC0 1.0 — public domain
The Blackwell School, where segregation had no law behind it
Version: 2CC0 1.0 — public domain
The Eagle Nebula, seen in the infrared
Version: 2CC0 1.0 — public domain
The house where the Equal Rights Amendment was written
Version: 2CC0 1.0 — public domain
The Aleutians, the forgotten front of the Second World War
Version: 2CC0 1.0 — public domain
The Cosmic Cliffs are not cliffs